CYP51 is an essential drug target for the treatment of primary amebic meningoencephalitis (PAM)

William Nes; C M Calvet; G Jennings; W. Zhou; A Aksenov; M R Luth; R Abagyn; William David Nes; J H Mckerrow; Larissa M Podust

CYP51 is an essential drug target for the treatment of primary amebic meningoencephalitis (PAM)

William Nes, C M Calvet, G Jennings, W. Zhou, A Aksenov, M R Luth, R Abagyn, William David Nes, J H Mckerrow, Larissa M Podust

Chemistry and Biochemistry

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	e0006104
Journal	Plos Neglected Tropical Disease
State	Published - Dec 15 2017

Cite this

@article{9417d19f87d1493cb261f08c17c5a6c7,

title = "CYP51 is an essential drug target for the treatment of primary amebic meningoencephalitis (PAM)",

author = "William Nes and Calvet, {C M} and G Jennings and W. Zhou and A Aksenov and Luth, {M R} and R Abagyn and Nes, {William David} and Mckerrow, {J H} and Podust, {Larissa M}",

year = "2017",

month = dec,

day = "15",

language = "English",

pages = "e0006104",

journal = "Plos Neglected Tropical Disease",

}

TY - JOUR

T1 - CYP51 is an essential drug target for the treatment of primary amebic meningoencephalitis (PAM)

AU - Nes, William

AU - Calvet, C M

AU - Jennings, G

AU - Zhou, W.

AU - Aksenov, A

AU - Luth, M R

AU - Abagyn, R

AU - Nes, William David

AU - Mckerrow, J H

AU - Podust, Larissa M

PY - 2017/12/15

Y1 - 2017/12/15

M3 - Article

SP - e0006104

JO - Plos Neglected Tropical Disease

JF - Plos Neglected Tropical Disease

ER -

CYP51 is an essential drug target for the treatment of primary amebic meningoencephalitis (PAM)

Fingerprint

Cite this